Progress of quinolones as antitumor agents

Chinese Pharmaceutical Journal

Volumn 39, Issue 12, 2004, Pages 890-894

  Wang, Xiao Tian ^a   Zhang, Jian Bin ^a   Lei, Ying Jie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ETOPOSIDE; GENISTEIN; OROBOL; QUINOLONE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESEARCH; DRUG STRUCTURE;

EID: 14744292724     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Andersen VE, Zaniewski RP, Kaczmarek FS, et al. Quinolones inhibit DNA religation mediated by staphylococcus aureus opoisomerase IV [J]. J Biol Chem, 1999,274(50):35927.
2. Kingma PS, Burden DA, Osheroff N, et al. Binding of etoposide to topoisomerase II in the absence of DNA: decreased affinity as a mechanism of drug resistance [J]. Biochemistry, 1999,38(12):3457.
3. Lavasani LS, Hiasa H. A parE-parC fusion protein is a functional topoisomerase [J]. Biochemistry, 2001,40:8438.
4. Fortune JM, Dickey JS, Lavrukhin OV, et al. Site-specific DNA cleavage by chlorella virus topoisomerase II [J]. Biochemistry, 2002, 41:11761.
5. Hiasa H. The Glu-84 of the parC subunit plays critical roles in both topoisomerase IV-Quinolone and topoisomerase IV-DNA interactions [J]. Biochemistry, 2002, 41:11779.
6. Anderson VE, Gootz TD, Osheroff N. Topoisomerase IV catalysis and the mechanism of quinolone action [J]. J Biol Chem, 1998,273(28): 17879.
7. Robinson MJ, Martin BA, Gootz TD, et al. Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: influence of the C-8 fluorine group [J]. Antimicrob Agents Chemother, 1992,36:751.
8. Strumberg D, Nitiss JL, Dong JW, et al. Importance of the fourth alpha-helix within the CAP homology domain of type II topoisomerase for DNA cleavage site recognition and quinolone action [J]. Antimicrob Agents Chemother, 2002,46:2735.
9. Gilligan PJ, McGuirk PR, Witty MJ. Antibiotic derivatives of 7-phenyl-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acids [P]. US, A61K, 4623650, 1986-11-18.
10. Bromberg KD, Burgin AB, Osheroff N. Quinolone action against human topoisomerase UR: stimulation of enzyme-mediated double-stranded DNA cleavage [J]. Biochemistry,2003, 42:3393.
11. Tabarrini O, Cecchetti V, Fravolini A, et al. Design and synthesis of modified quinolones as antitumoral acridones [J]. J Med Chem, 1999, 42:2136.
12. Clement JJ, Burres N, Jarvis K, et al. Biological characterization of a novel antitumor quinolone [J]. Cancer Research, 1995,55;830.
13. Kim MY, Duan WH, Gleason GM, et al. Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes [J]. J Med Chem, 2003,46:571.
14. Dong J, Walker JL, Nitiss JL. A mutation in yeast topoisomerase II that confers hypersensitivity to multiple classes of topoisomerase II Poisons [J]. J Biol Chem, 2000,275(11):7980.
15. Chen YL, Fang KC, Sheu JY, et al. Synthesis and antibacterial evaluation of certain quinolone derivatives [J]. J Med Chem, 2001, 44: 2374.
16. Li LP, Wang HK, Kuo SC, et al. Antitumor agents 155. synthesis and biological evaluation of 3′,6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents [J]. J Med Chem, 1994,37:3400.
17. Kuo SC, Lee HZ, Jang JP, et al. synthesis and cytotoxicity of 1,6, 7,8-substituted 2-(4′-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin [J]. J Med Chem, 1993,36:1146.
18. Xia Y, Yang ZY, Xia P, et al. Antitumor agents 211, fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents [J]. J Med Chem, 2001,44:3932.
19. Chen BC, Huang X, Wang J. A versatile synthesis of 2-alkyl and 2-aryl 4-quinolones [J]. Synthesis, 1987:483.
20. Xia Y, Yang ZY, Xia P, et al. Antitumor agents 181, synthesis and biological evaluation of 6,7,2′,3′,4′-substituted-1,2,3,4,- tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents [J]. J Med Chem, 1998,41:1155.
21. Li LP, Wang HK, Kuo SC, et al. Antitumor agents 150, 2′,3′, 4prime;, 5′,5,6,7-substituted 2-phenyl-4-quinolones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization [J]. J Med Chem, 1994,37:1126.
22. Zhang SX, Feng J, Kuo SC, et al. Antitumor agents 199, three-dimensional quantitative structure-activity relationship study of the colchicine binding site ligands using comparative molecular field analysis [J]. J Med Chem, 2000,43:167.
23. Traxler P, Green J, Mett H, et al. Use of pharmacophore model for the design of EGFR tyrosine kinase inhibitors: isoflavones and 3-phenyl-4 (1H)-quinolones [J]. J Med Chem, 1999,42;1018.
24. Joseph B, Darro F, Behard A, et al. 3-Aryl-2-quinolone derivatives: synthesis and characterization of in vitro an in vivo antitumor effects with emphasis on a new therapeutical target connected with cell migration [J]. J Med Chem, 2002,45:2543.
25. Koruznjak JD, Grdisa M, Slade N, et al. Novel derivatives of benzo [b]thieno[2,3-c]quinolones: synthesis, photochemical synthesis, and antitumor evaluation [J]. J Med Chem, 2003,46:4516.